Adverse Event Management

Brain Cancer

Breast Cancer

Disparities in Cancer Care

Drug Safety

Colorectal Cancer

Liver Cancer

Gastric Cancers

Gastrointestinal Cancer

Genetics

Kidney Carcinoma

Bladder Cancer

Prostate Cancer

Genitourinary Cancer

Graft vs Host Disease

Endometrial Cancer

Cervical Cancer

Ovarian Cancer

Gynecologic Cancers

Head and Neck Cancers

Leukemia

Multiple Myeloma

Lymphoma

Hematology

Immuno-Oncology

Lung Cancer

Myeloproliferative Neoplasms

Nurse Navigation

Pediatric Cancer

Practice Management

Prevention

Radiation Oncology

Sarcomas

Melanoma

Skin Cancer

Supportive Care

Survivorship

A subgroup of patients from the 3 CARTITUDE trials experienced cranial nerve palsy after treatment, most of whom were men. 

Cranial Nerve Palsy May Be Present After Cilta-Cel for Multiple Myeloma

As symptom severity can vary by patient, it is key for nurses to increase assessment for early intervention of patients with head and neck cancer following treatment, according to Meredith Cummings, PhD(c), BSN, RN, OCN.

Trajectory of Symptom Severity Aids Follow-Up in Head and Neck Cancer Treatment

Establishing a nurse-led system to administer tocilizumab in patients receiving bispecific antibodies tended to get the immunosuppressive drug to patients faster. 

Nurse-Driven Orders May Expedite Tocilizumab Administration for CRS

A feasibility study on the use of a mobile application for patients after undergoing a stem cell transplant may help care teams quickly identify and treat graft-versus-host disease. 

Patient-Reported Symptoms via Mobile App May Help Expedite GVHD Identification, Treatment

News

Latest News

FDA News

Survivorship 

Contributors

Media

Expert Connections

The Vitals

Podcasts

Videos

Conferences

Conference Coverage

Conference Listing

Publications

CME/CE

Continuing Education

Resources

Case-Based Digest 

Rx Road Map

Webinars

Cancer Summary Slides

MPN Symptom Management

Events

Subscribe

Partners

Articles

CancerNetwork.com

CureToday.com

OncLive.com

TargetedOnc.com

Advertise

Privacy

Terms & Conditions

Do Not Sell My Information

Oncology Nursing News

Facebook

Twitter

LinkedIn

Specialty

Advanced Practice Providers

Clinical

Gynecologic Cancer

Immunotherapy

Quality Improvement

Sap Partners

Is your organization missing from this list? Reach out to Leyla Cakici, Strategic Alliance Partnership Coordinator, to learn more about the complimentary strategic partnership program: 

1rem

Strategic Alliance Partners

IMBCR is dedicated to advance the treatment of myeloma by connecting possibility through scientific innovation leading to personalized and continuous optimized patient care.

Institute for Myeloma & Bone Cancer Research

Institute for Myeloma & Bone Cancer Research | Strategic Alliance Partners

Latest from Institute for Myeloma & Bone Cancer Research

Latest Conference Coverage